Diabetes Care, Vol 18, Issue 5 708-714, Copyright © 1995 by American Diabetes Association

ARTICLES

Diabetic cardiomyopathy. A unique entity or a complication of coronary artery disease?

DS Bell
University of Alabama at Birmingham School of Medicine, USA.

The increased incidence of congestive heart failure and the increased mortality and morbidity in the diabetic patient following myocardial infarction or coronary artery bypass graft can be explained by the presence of diabetic cardiomyopathy. Noninvasive studies in young diabetic patients show no cardiac abnormality, but in older diabetic patients mild cardiac diastolic dysfunction is detectable. This mild cardiomyopathy can become clinically detectable in the presence of hypertension and can be severe in the presence of myocardial ischemia. Microvascular disease is unlikely to cause diabetic cardiomyopathy. Cellular changes, including defects in calcium transport and fatty acid metabolism, may lead to myocellular hypertrophy and myocardial fibrosis, initially causing diastolic dysfunction that may advance to systolic dysfunction. Glycemic control, energetic detection and treatment of hypertension with appropriate antihypertensive agents, and early detection and treatment of ischemic heart disease are essential in preventing and treating diabetic cardiomyopathy.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				L. Zhang, M. B. Cannell, A. R.J. Phillips, G. J.S. Cooper, and M.-L. Ward Altered Calcium Homeostasis Does Not Explain the Contractile Deficit of Diabetic Cardiomyopathy Diabetes, August 1, 2008; 57(8): 2158 - 2166. [Abstract] [Full Text] [PDF]

				M. Ueno, J. Suzuki, Y. Zenimaru, S. Takahashi, T. Koizumi, S. Noriki, O. Yamaguchi, K. Otsu, W.-J. Shen, F. B. Kraemer, et al. Cardiac overexpression of hormone-sensitive lipase inhibits myocardial steatosis and fibrosis in streptozotocin diabetic mice Am J Physiol Endocrinol Metab, June 1, 2008; 294(6): E1109 - E1118. [Abstract] [Full Text] [PDF]

				H. Bahrami, D. A. Bluemke, R. Kronmal, A. G. Bertoni, D. M. Lloyd-Jones, E. Shahar, M. Szklo, and J. A.C. Lima Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study. J. Am. Coll. Cardiol., May 6, 2008; 51(18): 1775 - 1783. [Abstract] [Full Text] [PDF]

				S. Kobayashi, K. Mao, H. Zheng, X. Wang, C. Patterson, T. D. O'Connell, and Q. Liang Diminished GATA4 Protein Levels Contribute to Hyperglycemia-induced Cardiomyocyte Injury J. Biol. Chem., July 27, 2007; 282(30): 21945 - 21952. [Abstract] [Full Text] [PDF]

				E. Arikawa, R. C.W. Ma, K. Isshiki, I. Luptak, Z. He, Y. Yasuda, Y. Maeno, M. E. Patti, G. C. Weir, R. A. Harris, et al. Effects of Insulin Replacements, Inhibitors of Angiotensin, and PKC{beta}'s Actions to Normalize Cardiac Gene Expression and Fuel Metabolism in Diabetic Rats Diabetes, May 1, 2007; 56(5): 1410 - 1420. [Abstract] [Full Text] [PDF]

				D. Qi and B. Rodrigues Glucocorticoids produce whole body insulin resistance with changes in cardiac metabolism Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E654 - E667. [Abstract] [Full Text] [PDF]

				V. Subramanian, P. Krishnamurthy, K. Singh, and M. Singh Lack of osteopontin improves cardiac function in streptozotocin-induced diabetic mice Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H673 - H683. [Abstract] [Full Text] [PDF]

				D. An and B. Rodrigues Role of changes in cardiac metabolism in development of diabetic cardiomyopathy Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1489 - H1506. [Abstract] [Full Text] [PDF]

				L. R. Goldberg and M. Jessup Stage B Heart Failure: Management of Asymptomatic Left Ventricular Systolic Dysfunction Circulation, June 20, 2006; 113(24): 2851 - 2860. [Full Text] [PDF]

				S. Itoh, B. Ding, T. Shishido, N. Lerner-Marmarosh, N. Wang, N. Maekawa, B. C. Berk, Y. Takeishi, C. Yan, B. C. Blaxall, et al. Role of p90 Ribosomal S6 Kinase-Mediated Prorenin-Converting Enzyme in Ischemic and Diabetic Myocardium Circulation, April 11, 2006; 113(14): 1787 - 1798. [Abstract] [Full Text] [PDF]

				R. E. Gilbert, K. Connelly, D. J. Kelly, C. A. Pollock, and H. Krum Heart Failure and Nephropathy: Catastrophic and Interrelated Complications of Diabetes Clin. J. Am. Soc. Nephrol., March 1, 2006; 1(2): 193 - 208. [Abstract] [Full Text] [PDF]

				A. P. Kengne, A. G.B. Amoah, and J.-C. Mbanya Cardiovascular Complications of Diabetes Mellitus in Sub-Saharan Africa Circulation, December 6, 2005; 112(23): 3592 - 3601. [Abstract] [Full Text] [PDF]

				A. Malhotra, R. Begley, B. P. S. Kang, I. Rana, J. Liu, G. Yang, D. Mochly-Rosen, and L. G. Meggs PKC-{varepsilon}-dependent survival signals in diabetic hearts Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1343 - H1350. [Abstract] [Full Text] [PDF]

				G. Perseghin, P. Fiorina, F. De Cobelli, P. Scifo, A. Esposito, T. Canu, M. Danna, C. Gremizzi, A. Secchi, L. Luzi, et al. Cross-Sectional Assessment of the Effect of Kidney and Kidney-Pancreas Transplantation on Resting Left Ventricular Energy Metabolism in Type 1 Diabetic-Uremic Patients: A Phosphorous-31 Magnetic Resonance Spectroscopy Study J. Am. Coll. Cardiol., September 20, 2005; 46(6): 1085 - 1092. [Abstract] [Full Text] [PDF]

				A. M. Kanaya, D. Herrington, E. Vittinghoff, F. Lin, V. Bittner, J. A. Cauley, S. Hulley, and E. Barrett-Connor Impaired Fasting Glucose and Cardiovascular Outcomes in Postmenopausal Women with Coronary Artery Disease Ann Intern Med, May 17, 2005; 142(10): 813 - 820. [Abstract] [Full Text] [PDF]

				Z. He, K. J. Way, E. Arikawa, E. Chou, D. M. Opland, A. Clermont, K. Isshiki, R. C. W. Ma, J. A. Scott, F. J. Schoen, et al. Differential Regulation of Angiotensin II-induced Expression of Connective Tissue Growth Factor by Protein Kinase C Isoforms in the Myocardium J. Biol. Chem., April 22, 2005; 280(16): 15719 - 15726. [Abstract] [Full Text] [PDF]

				J. Martin, D. J. Kelly, S. A. Mifsud, Y. Zhang, A. J. Cox, F. See, H. Krum, J. Wilkinson-Berka, and R. E. Gilbert Tranilast attenuates cardiac matrix deposition in experimental diabetes: role of transforming growth factor-{beta} Cardiovasc Res, February 15, 2005; 65(3): 694 - 701. [Abstract] [Full Text] [PDF]

				K. Bibbins-Domingo, F. Lin, E. Vittinghoff, E. Barrett-Connor, S. B. Hulley, D. Grady, and M. G. Shlipak Predictors of Heart Failure Among Women With Coronary Disease Circulation, September 14, 2004; 110(11): 1424 - 1430. [Abstract] [Full Text] [PDF]

				H. S. Lim, R. J. MacFadyen, and G. Y. H. Lip Diabetes Mellitus, the Renin-Angiotensin-Aldosterone System, and the Heart Arch Intern Med, September 13, 2004; 164(16): 1737 - 1748. [Abstract] [Full Text] [PDF]

				R. M. Witteles, W. H. W. Tang, A. H. Jamali, J. W. Chu, G. M. Reaven, and M. B. Fowler Insulin resistance in idiopathic dilated cardiomyopathy: A possible etiologic link J. Am. Coll. Cardiol., July 7, 2004; 44(1): 78 - 81. [Abstract] [Full Text] [PDF]

				D. S.H. Bell Heart Failure: A Serious and Common Comorbidity of Diabetes Clin. Diabetes, April 1, 2004; 22(2): 61 - 65. [Abstract] [Full Text] [PDF]

				K. R. Bidasee, Y. Zhang, C. H. Shao, M. Wang, K. P. Patel, U. D. Dincer, and H. R. Besch Diabetes Increases Formation of Advanced Glycation End Products on Sarco(endo)plasmic Reticulum Ca2+-ATPase Diabetes, February 1, 2004; 53(2): 463 - 473. [Abstract] [Full Text]

				A. G. Bertoni, A. Tsai, E. K. Kasper, and F. L. Brancati Diabetes and Idiopathic Cardiomyopathy: A nationwide case-control study Diabetes Care, October 1, 2003; 26(10): 2791 - 2795. [Abstract] [Full Text] [PDF]

				D. S.H. Bell Diabetic Cardiomyopathy Diabetes Care, October 1, 2003; 26(10): 2949 - 2951. [Full Text] [PDF]

				E. A. Mokelke, Q. Hu, M. Song, L. Toro, H. K. Reddy, and M. Sturek Altered functional coupling of coronary K+ channels in diabetic dyslipidemic pigs is prevented by exercise J Appl Physiol, September 1, 2003; 95(3): 1179 - 1193. [Abstract] [Full Text] [PDF]

				D. S.H. Bell Heart Failure: The frequent, forgotten, and often fatal complication of diabetes Diabetes Care, August 1, 2003; 26(8): 2433 - 2441. [Abstract] [Full Text] [PDF]

				M. Diamant, H. J. Lamb, Y. Groeneveld, E. L. Endert, J. W. A. Smit, J. J. Bax, J. A. Romijn, A. de Roos, and J. K. Radder Diastolic dysfunction is associatedwith altered myocardial metabolism inasymptomatic normotensive patientswith well-controlled type 2 diabetes mellitus J. Am. Coll. Cardiol., July 16, 2003; 42(2): 328 - 335. [Abstract] [Full Text] [PDF]

				K. R. Bidasee, K. Nallani, Y. Yu, R. R. Cocklin, Y. Zhang, M. Wang, U. D. Dincer, and H. R. Besch Jr. Chronic Diabetes Increases Advanced Glycation End Products on Cardiac Ryanodine Receptors/Calcium-Release Channels Diabetes, July 1, 2003; 52(7): 1825 - 1836. [Abstract] [Full Text] [PDF]

				R. Candido, J. M. Forbes, M. C. Thomas, V. Thallas, R. G. Dean, W. C. Burns, C. Tikellis, R. H. Ritchie, S. M. Twigg, M. E. Cooper, et al. A Breaker of Advanced Glycation End Products Attenuates Diabetes-Induced Myocardial Structural Changes Circ. Res., April 18, 2003; 92(7): 785 - 792. [Abstract] [Full Text] [PDF]

				M. Bartnik, K. Malmberg, and L. Ryden Diabetes and the heart: compromised myocardial function -- a common challenge Eur. Heart J. Suppl., January 1, 2003; 5(suppl_B): B33 - B41. [Abstract] [PDF]

				L. Virag and C. Szabo The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors Pharmacol. Rev., September 1, 2002; 54(3): 375 - 429. [Abstract] [Full Text] [PDF]

				H. Taegtmeyer, P. McNulty, and M. E. Young Adaptation and Maladaptation of the Heart in Diabetes: Part I: General Concepts Circulation, April 9, 2002; 105(14): 1727 - 1733. [Full Text] [PDF]

				P. Pacher, L. Liaudet, F. G. Soriano, J. G. Mabley, E. Szabo, and C. Szabo The Role of Poly(ADP-Ribose) Polymerase Activation in the Development of Myocardial and Endothelial Dysfunction in Diabetes Diabetes, February 1, 2002; 51(2): 514 - 521. [Abstract] [Full Text] [PDF]

				K. R. Bidasee, U. D. Dincer, and H. R. Besch Jr. Ryanodine Receptor Dysfunction in Hearts of Streptozotocin-Induced Diabetic Rats Mol. Pharmacol., December 1, 2001; 60(6): 1356 - 1364. [Abstract] [Full Text] [PDF]

				A. Tardif, N. Julien, A. Pelletier, G. Thibault, A. K. Srivastava, J.-L. Chiasson, and L. Coderre Chronic exposure to beta -hydroxybutyrate impairs insulin action in primary cultures of adult cardiomyocytes Am J Physiol Endocrinol Metab, December 1, 2001; 281(6): E1205 - E1212. [Abstract] [Full Text] [PDF]

				A. Malhotra, B. P.S. Kang, S. Cheung, D. Opawumi, and L. G. Meggs Angiotensin II Promotes Glucose-Induced Activation of Cardiac Protein Kinase C Isozymes and Phosphorylation of Troponin I Diabetes, August 1, 2001; 50(8): 1918 - 1926. [Abstract] [Full Text] [PDF]

				C. Iribarren, A. J. Karter, A. S. Go, A. Ferrara, J. Y. Liu, S. Sidney, and J. V. Selby Glycemic Control and Heart Failure Among Adult Patients With Diabetes Circulation, June 5, 2001; 103(22): 2668 - 2673. [Abstract] [Full Text] [PDF]

				H. M. Colhoun, M. B. Rubens, S. R. Underwood, and J. H. Fuller The effect of type 1 diabetes mellitus on the gender difference in coronary artery calcification J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2160 - 2167. [Abstract] [Full Text] [PDF]

				D. KOYA, J. W. DENNIS, C. E. WARREN, N. TAKAHARA, F. J. SCHOEN, Y. NISHIO, T. NAKAJIMA, M. A. LIPES, and G. L. KING Overexpression of core 2 N-acetylglycosaminyltransferase enhances cytokine actions and induces hypertrophic myocardium in transgenic mice FASEB J, December 1, 1999; 13(15): 2329 - 2337. [Abstract] [Full Text]

				G. Davey and P. Mckeigue Insulin infusion in diabetic patients with acute myocardial infarction BMJ, September 14, 1996; 313(7058): 639 - 640. [Full Text]

				A. I. M. Al-Shafei, R. G. Wise, G. A. Gresham, G. Bronns, T. A. Carpenter, L. D. Hall, and C. L.-H. Huang Non-invasive magnetic resonance imaging assessment of myocardial changes and the effects of angiotensin-converting enzyme inhibition in diabetic rats J. Physiol., January 9, 2002; 538(2): 541 - 553. [Abstract] [Full Text] [PDF]

				A. I. M. Al-Shafei, R. G. Wise, G. A. Gresham, T. A. Carpenter, L. D. Hall, and C. L.-H. Huang Magnetic resonance imaging analysis of cardiac cycle events in diabetic rats: the effect of angiotensin-converting enzyme inhibition J. Physiol., January 9, 2002; 538(2): 555 - 572. [Abstract] [Full Text] [PDF]